The uptake and retention of metaiodobenzyl guanidine by the neuroblastoma cell line NB1-G
1991
Uptake and Retention of mIBG by Neuroblastoma Cells
publication
Evidence: moderate
Author Information
Author(s): R.J. Mairs, M.N. Gaze, A. Barrett
Primary Institution: University of Glasgow Department of Radiation Oncology
Hypothesis
The study aims to define the pharmacokinetics of mIBG uptake and retention by the neuroblastoma cell line NB1-G.
Conclusion
The human neuroblastoma cell line NB1-G shows active uptake of mIBG, which is temperature, sodium, and oxygen dependent.
Supporting Evidence
- NB1-G cells show active uptake of mIBG similar to adrenal medullary cells.
- Uptake of mIBG is saturable and can be blocked by specific inhibitors.
- Most of the accumulated mIBG quickly leaves the cells after uptake.
Takeaway
The NB1-G cells can take in a special medicine called mIBG, which helps treat a type of cancer, but they don't keep it for long.
Methodology
Cells were cultured and incubated with mIBG, and various drugs were tested for their effect on mIBG uptake and retention.
Limitations
The study does not explore the long-term effects of mIBG retention in vivo.
Want to read the original?
Access the complete publication on the publisher's website